LRRK2 and Parkinson disease: We performed a retrospective post hoc power analysis and confirmed that the experimental groups were sufficiently powered to reveal differences in the transcriptomes of all patients with PD at both time points, except for the LRRK2 G2019S group at visit 8, which was therefore excluded from further analyses (Extended Data Fig. 2a,b).